Among people in New Zealand, the proportion of individuals with multiple sclerosis (MS) — the disease’s prevalence, or how common it is — has grown by about one-third in recent decades, a new study ...

Nura Bio has launched a Phase 1 clinical trial evaluating NB-4746, its investigational treatment for multiple sclerosis (MS) and several other neurological conditions, in healthy volunteers. The trial ...

A five-week, high-intensity video game-based exercise program called exergaming outperformed other forms of exercise at easing symptoms and improving life quality in people with multiple sclerosis (MS ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit A company is trying to create a generic needs to obtain samples of the brand-name medication that ...

Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see all the latest stories from the ...

My adolescent years can be characterized by a series of naps, long-lasting migraines, always being sick, and never being able to donate blood, which my family and I never understood. My journey with ...

Human glial progenitor cells — forerunners of nerve cells that protect and support neurons — transplanted into adult mice in a model of multiple sclerosis (MS) were seen to restore myelin production ...

What is privosegtor for MS? Privosegtor, previously known as OCS-05 and BN201, is an experimental small molecule being developed by Oculis to treat acute optic neuritis, a common symptom of multiple ...

Bruce Bebo, PhD, executive vice president of research at the National Multiple Sclerosis Society, outlines the organization’s focus on stopping MS progression, repairing lost function, and preventing ...

A few years ago, after a fairly stable decade, my MS decided to shake things up. What began as occasional tripping over my own feet soon turned into chronic shin splints, and the inability to walk or ...